Cinanserin

This classification denotes a serotonin antagonist with the molecular formula C20H24N2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KI6J9OY7A3, chemically known as 2-propenamide, n-(2-((3-(dimethylamino)propyl)thio)phenyl)-3-phenyl- but generally known as cinanserin, which bears US NIH Compound Identifier 5475158. European Medicines Agency schedules Cinanserin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06285MIG. The term CINANSERIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). CINANSERIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cinanserin under HS 29309085 and SITC 51549. As of Q4 2014, CINANSERIN remains the US FDA Preferred Term for this commodity. Cinanserin bears US NLM identifiers UMLS ID C0008788 and NCI Concept Code C83624. SMILES: S(CCCN(C)C)c1c(NC(=O)/C=C/c2ccccc2)cccc1.